Ocular Therapeutix (OCUL) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to -$1.2 billion.
- Ocular Therapeutix's Retained Earnings fell 2984.44% to -$1.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.2 billion, marking a year-over-year decrease of 2984.44%. This contributed to the annual value of -$1.2 billion for FY2025, which is 2984.44% down from last year.
- Latest data reveals that Ocular Therapeutix reported Retained Earnings of -$1.2 billion as of Q4 2025, which was down 2984.44% from -$1.1 billion recorded in Q3 2025.
- Ocular Therapeutix's Retained Earnings' 5-year high stood at -$536.1 million during Q1 2021, with a 5-year trough of -$1.2 billion in Q4 2025.
- Moreover, its 5-year median value for Retained Earnings was -$668.1 million (2023), whereas its average is -$736.6 million.
- Over the last 5 years, Ocular Therapeutix's Retained Earnings had its largest YoY gain of 121.52% in 2021, and its largest YoY loss of 3233.63% in 2021.
- Over the past 5 years, Ocular Therapeutix's Retained Earnings (Quarter) stood at -$545.8 million in 2021, then dropped by 13.02% to -$616.8 million in 2022, then fell by 13.09% to -$697.6 million in 2023, then decreased by 27.74% to -$891.1 million in 2024, then decreased by 29.84% to -$1.2 billion in 2025.
- Its Retained Earnings stands at -$1.2 billion for Q4 2025, versus -$1.1 billion for Q3 2025 and -$1.0 billion for Q2 2025.